STRYKER CORP false 0000310764 0000310764 2023-12-11 2023-12-11 0000310764 us-gaap:CommonStockMember 2023-12-11 2023-12-11 0000310764 syk:SeniorUnsecuredNotes0.250Due2024Member 2023-12-11 2023-12-11 0000310764 syk:SeniorUnsecuredNotes2.125Due2027Member 2023-12-11 2023-12-11 0000310764 syk:SeniorUnsecuredNotes0.750Due2029Member 2023-12-11 2023-12-11 0000310764 syk:SeniorUnsecuredNotes2.625Due2030Member 2023-12-11 2023-12-11 0000310764 syk:SeniorUnsecuredNotes1.000Due2031Member 2023-12-11 2023-12-11

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 11, 2023

 

 

 

LOGO

STRYKER CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Michigan   001-13149   38-1239739

(State

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employee

Identification No.)

 

2825 Airview Boulevard, Kalamazoo, Michigan   49002
(Address of principal executive offices)   (Zip Code)

(269) 385-2600

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange
on which registered

Common Stock, $.10 Par Value   SYK   New York Stock Exchange
0.250% Notes due 2024   SYK24A   New York Stock Exchange
2.125% Notes due 2027   SYK27   New York Stock Exchange
0.750% Notes due 2029   SYK29   New York Stock Exchange
2.625% Notes due 2030   SYK30   New York Stock Exchange
1.000% Notes due 2031   SYK31   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging Growth Company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


ITEM 1.01

ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT

On December 11, 2023, Stryker Corporation (the “Company”) completed a public offering (the “Offering”) of €600,000,000 aggregate principal amount of the Company’s 3.375% Notes due 2028 (the “Notes”).

The Notes were sold pursuant to an Underwriting Agreement, dated December 6, 2023 (the “Underwriting Agreement”), between the Company and Barclays Bank PLC, Goldman Sachs & Co. LLC, Mizuho International plc and Wells Fargo Securities International Limited, as representatives of the underwriters. The Offering was made pursuant to the Company’s Automatic Shelf Registration Statement on Form S-3 (File No. 333-275853) and the Prospectus included therein, filed with the Securities and Exchange Commission on December 1, 2023, and supplemented by the Prospectus Supplement dated December 6, 2023.

The Notes were issued under an Indenture, dated January 15, 2010 (the “Base Indenture”), between the Company and U.S. Bank Trust Company, National Association, as successor in interest to U.S. Bank, National Association, as trustee (the “Trustee”), as supplemented by the Twenty-Seventh Supplemental Indenture, dated December 11, 2023, between the Company and the Trustee (the “Supplemental Indenture” and, the Base Indenture as so supplemented, the “Indenture”).

The Notes will bear interest at a rate of 3.375% per year. Interest on the Notes is payable on December 11 of each year, commencing on December 11, 2024. The Notes will mature on December 11, 2028.

The Company may redeem the Notes at its option, in whole, but not in part, for cash, at any time prior to their maturity at a price equal to 100% of the outstanding principal amount of the Notes, plus accrued and unpaid interest to, but not including, the redemption date, if certain tax events occur that would obligate the Company to pay additional amounts as described in the Indenture. In addition, prior to September 11, 2028, the Company may redeem the Notes at the Company’s option for cash, any time in whole or from time to time in part, at a redemption price that includes accrued and unpaid interest and the applicable make-whole premium, as specified in the Indenture. However, no make-whole premium will be paid for redemption of the Notes on or after September 11, 2028.

The Company expects to receive net proceeds of approximately €597 million (or $649 million based on an exchange rate of €1 to $1.0878 on December 1, 2023, as published by the U.S. Federal Reserve Board), after deducting the underwriting discount and the Company’s estimated expenses related to the Offering. The Company intends to use the net proceeds from the Offering for general corporate purposes.

The Company may issue additional debt from time to time pursuant to the Indenture. The Indenture contains covenants that limit the Company’s ability to, among other things, incur certain liens securing indebtedness, engage in certain sale and leaseback transactions, and enter into certain consolidations, mergers, conveyances, transfers or leases of all or substantially all of the Company’s assets. Subject to certain limitations, in the event of the occurrence of both (1) a change of control of the Company and (2) a downgrade of the Notes below investment grade rating by both Moody’s Investors’ Services, Inc. and Standard & Poor’s Ratings Services within a specified time period, the Company will be required to make an offer to purchase the Notes at a price equal to 101% of the principal amount of the Notes, plus accrued and unpaid interest to, but not including, the date of repurchase.

The foregoing description of the Underwriting Agreement, the Base Indenture and the Supplemental Indenture does not purport to be complete and is qualified in its entirety by reference to the full text of such documents, which are filed as Exhibits 1.1, 4.1 and 4.2 hereto, respectively, and incorporated herein by reference.

 

ITEM 2.03

CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT

The information set forth in Item 1.01 above with respect to the Notes is hereby incorporated by reference into this Item 2.03, insofar as it relates to the creation of a direct financial obligation.


ITEM 9.01

FINANCIAL STATEMENTS AND EXHIBITS

 

Exhibit
No.
   Description
  1.1    Underwriting Agreement, dated December 6, 2023, between Stryker Corporation and Barclays Bank PLC, Goldman Sachs & Co. LLC, Mizuho International plc and Wells Fargo Securities International Limited, as representatives of the underwriters.
  4.1    Indenture, dated January 15, 2010, between Stryker Corporation and U.S. Bank National Association, as trustee (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K, dated January 15, 2010 (Commission File No. 000-09165)).
  4.2    Twenty-Seventh Supplemental Indenture (including the form of the note), dated December 11, 2023, between Stryker Corporation and U.S. Bank Trust Company, National Association, as trustee.
  5.1    Opinion of Sullivan & Cromwell LLP regarding the validity of the Notes.
  5.2    Opinion of Warner Norcross + Judd LLP regarding the validity of the Notes.
23.1    Consent of Sullivan & Cromwell LLP (included as part of Exhibit 5.1).
23.2    Consent of Warner Norcross + Judd LLP (included as part of Exhibit 5.2).
104    Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document).


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    Stryker Corporation
    (Registrant)
Dated: December 11, 2023     By:  

/s/ Glenn S. Boehnlein

    Name:   Glenn S. Boehnlein
    Title:   Vice President, Chief Financial Officer